Ponaxen 15 Mg Tablets In Pakistan
Ponaxen 15 Mg Tablets In Pakistan Incorporate Ponatinib, a Third-era Tyrosine Kinase Inhibitor (Tki) Designed to Target Odd Proteins That Pressure the Increase of Certain Blood Cancers. It's Far Mainly Effective in Opposition to Leukemia Cells Wearing the T315i Mutation, a Genetic Alteration That Can Make Different Remedies Useless. Ponatinib Works by Way of Blocking Off the Interest of Bcr-abl and Different Cancer-promoting Kinases, Helping to Sluggish or Prevent the Growth and Unfold of Malignant Blood Cells.
How It Works
Ponatinib Blocks the Atypical Bcr-abl Tyrosine Kinase Protein Accountable for the Growth of Leukemia Cells. It Remains Powerful in Opposition to Numerous Resistant Mutations, Together With T315i.
Dosage
Treatment Ought to Most Effective Be Started and Monitored by an Oncologist or Hematologist.
General Starting Dose is Typically Forty Five Mg as Soon as Each Day.
The Dose May Be Decreased to 30 Mg or 15 Mg Every Day Depending on Treatment Reaction and Facet Results.